Dean S. Carson

2.7k total citations
23 papers, 2.0k citations indexed

About

Dean S. Carson is a scholar working on Social Psychology, Endocrine and Autonomic Systems and Pharmacy. According to data from OpenAlex, Dean S. Carson has authored 23 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Social Psychology, 11 papers in Endocrine and Autonomic Systems and 6 papers in Pharmacy. Recurrent topics in Dean S. Carson's work include Neuroendocrine regulation and behavior (22 papers), Neuroscience of respiration and sleep (11 papers) and Infant Health and Development (6 papers). Dean S. Carson is often cited by papers focused on Neuroendocrine regulation and behavior (22 papers), Neuroscience of respiration and sleep (11 papers) and Infant Health and Development (6 papers). Dean S. Carson collaborates with scholars based in United States, Australia and United Kingdom. Dean S. Carson's co-authors include Adam J. Guastella, Iain S. McGregor, Mark R. Dadds, Philip B. Mitchell, Joseph P. Garner, Karen J. Parker, Antonio Y. Hardan, Alexandra Howard, Robin A. Libove and Jennifer M. Phillips and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Dean S. Carson

23 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dean S. Carson United States 20 1.6k 584 542 474 340 23 2.0k
Alexandre Charlet France 18 1.3k 0.8× 571 1.0× 360 0.7× 313 0.7× 105 0.3× 38 1.8k
Jessie L. Frijling Netherlands 20 1.1k 0.7× 234 0.4× 511 0.9× 206 0.4× 566 1.7× 34 1.9k
Harald Gruppe Germany 11 1.0k 0.6× 183 0.3× 568 1.0× 236 0.5× 305 0.9× 21 1.6k
Yannis Paloyelis United Kingdom 23 824 0.5× 260 0.4× 453 0.8× 236 0.5× 354 1.0× 43 1.7k
Josephine M. Johns United States 27 1.3k 0.8× 418 0.7× 218 0.4× 144 0.3× 308 0.9× 63 1.9k
Meera E. Modi United States 18 701 0.4× 184 0.3× 355 0.7× 152 0.3× 173 0.5× 28 1.2k
Saskia B.J. Koch Netherlands 24 755 0.5× 146 0.3× 547 1.0× 120 0.3× 601 1.8× 55 1.9k
Rose C. Mantella United States 11 555 0.3× 193 0.3× 382 0.7× 107 0.2× 236 0.7× 13 1.1k
Laura M. Holsen United States 28 303 0.2× 594 1.0× 251 0.5× 93 0.2× 1.0k 2.9× 72 2.5k
Kelly M. Dumais United States 12 773 0.5× 227 0.4× 342 0.6× 110 0.2× 76 0.2× 17 970

Countries citing papers authored by Dean S. Carson

Since Specialization
Citations

This map shows the geographic impact of Dean S. Carson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean S. Carson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean S. Carson more than expected).

Fields of papers citing papers by Dean S. Carson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean S. Carson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean S. Carson. The network helps show where Dean S. Carson may publish in the future.

Co-authorship network of co-authors of Dean S. Carson

This figure shows the co-authorship network connecting the top 25 collaborators of Dean S. Carson. A scholar is included among the top collaborators of Dean S. Carson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean S. Carson. Dean S. Carson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carson, Dean S., et al.. (2023). Caregiver Burden and Its Relationship to Health-Related Quality of Life in Craniopharyngioma Survivors. The Journal of Clinical Endocrinology & Metabolism. 109(1). e76–e87. 14 indexed citations
2.
Carson, Dean S., et al.. (2022). Postnatal oxytocin treatment improves survival and neurodevelopmental outcomes in an animal model of neonatal abstinence syndrome. SHILAP Revista de lepidopterología. 11. 100143–100143. 3 indexed citations
3.
Yeomans, David C., Leah R. Hanson, Dean S. Carson, et al.. (2021). Nasal oxytocin for the treatment of psychiatric disorders and pain: achieving meaningful brain concentrations. Translational Psychiatry. 11(1). 388–388. 32 indexed citations
4.
Parker, Karen J., Ozge Oztan, Robin A. Libove, et al.. (2019). A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism. Science Translational Medicine. 11(491). 107 indexed citations
5.
Oztan, Ozge, Robin A. Libove, Lisa P. Jackson, et al.. (2019). Blood oxytocin concentration positively predicts contagious yawning behavior in children with autism spectrum disorder. Autism Research. 12(8). 1156–1161. 14 indexed citations
6.
Parker, Karen J., Ozge Oztan, Robin A. Libove, et al.. (2017). Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism. Proceedings of the National Academy of Sciences. 114(30). 8119–8124. 246 indexed citations
7.
Woolley, Josh, et al.. (2016). The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study. Psychopharmacology. 233(13). 2571–2580. 37 indexed citations
8.
Carson, Dean S., Joseph P. Garner, Shellie A. Hyde, et al.. (2015). Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism. PLoS ONE. 10(7). e0132224–e0132224. 52 indexed citations
9.
Johnston, Jennifer, Nicholas Lintzeris, David J. Allsop, et al.. (2014). Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting. Psychopharmacology. 231(24). 4623–4636. 29 indexed citations
10.
Carson, Dean S., Sean Berquist, Joseph P. Garner, et al.. (2014). Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children. Molecular Psychiatry. 20(9). 1085–1090. 158 indexed citations
11.
Garner, Joseph P., Dean S. Carson, Jennifer Keller, et al.. (2014). Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol. Journal of Psychiatric Research. 51. 30–36. 76 indexed citations
12.
Carson, Dean S., Christopher L. Howerton, Joseph P. Garner, et al.. (2014). Plasma vasopressin concentrations positively predict cerebrospinal fluid vasopressin concentrations in human neonates. Peptides. 61. 12–16. 23 indexed citations
13.
Parker, Karen J., Joseph P. Garner, Robin A. Libove, et al.. (2014). Plasma oxytocin concentrations and OXTR polymorphisms predict social impairments in children with and without autism spectrum disorder. Proceedings of the National Academy of Sciences. 111(33). 12258–12263. 167 indexed citations
14.
Carson, Dean S., et al.. (2013). A brief history of oxytocin and its role in modulating psychostimulant effects. Journal of Psychopharmacology. 27(3). 231–247. 82 indexed citations
15.
Carson, Dean S., et al.. (2012). Preliminary evidence for lowered basal cortisol in a naturalistic sample of methamphetamine polydrug users.. Experimental and Clinical Psychopharmacology. 20(6). 497–503. 29 indexed citations
16.
Bowen, Michael T., Dean S. Carson, Adena S. Spiro, Jonathon C. Arnold, & Iain S. McGregor. (2011). Adolescent Oxytocin Exposure Causes Persistent Reductions in Anxiety and Alcohol Consumption and Enhances Sociability in Rats. PLoS ONE. 6(11). e27237–e27237. 122 indexed citations
17.
Guastella, Adam J., et al.. (2010). Intranasal Arginine Vasopressin Enhances the Encoding of Happy and Angry Faces in Humans. Biological Psychiatry. 67(12). 1220–1222. 98 indexed citations
18.
Carson, Dean S., Glenn E. Hunt, Adam J. Guastella, et al.. (2010). Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addiction Biology. 15(4). 448–463. 116 indexed citations
19.
Guastella, Adam J., Alexandra Howard, Mark R. Dadds, Philip B. Mitchell, & Dean S. Carson. (2009). A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology. 34(6). 917–923. 273 indexed citations
20.
Carson, Dean S., Jennifer L. Cornish, Adam J. Guastella, Glenn E. Hunt, & Iain S. McGregor. (2009). Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology. 58(1). 38–43. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026